|
News Feeds |
|
Health News from Medical News Today
|
Latest Health News and Medical News posted throughout the day, every day.
|
-
BioAlliance Pharma Announces The Grant Of Its European Acyclovir Lauriad(R) Patent
BioAlliance Pharma SA (Paris:BIO)(Euronext Paris - BIO), a company dedicated to the supportive care and treatment of cancer patients, announced the grant of a European patent protecting its product acyclovir Lauriad®. This patent is now validated in all European countries; this first patent validation is a major step and the procedures up to the grant are ongoing in the other major global areas, America and Asia. This patent specifically protects the muco-adhesive tablet containing acyclovir, its process for manufacturing and its clinical application...


-
Survey Reveals Cereal Tops The List Of Preferred Ways To Serve A Quick And Nutritious Breakfast
A recent Kix® survey shows 79 percent of parents eat breakfast with their children, and the majority (96 percent) agree it's essential to pass along healthy habits and good nutrition. As parents shift back to routine, busier schedules leave many looking for simple solutions to meet the nutritional and developmental needs of their "big kids'" growing bodies. Data published in the Journal of the American Dietetic Association shows frequent cereal eaters, including kids, tend to have healthier body weights, making cereal an important part of the busy morning ritual for many families...


-
GE Awarded $538,000 Grant From National Institutes Of Health For Human Microbiome Studies
Researchers from GE Global Research have been awarded a $538,000 human microbiome project from the National Institutes of Health (NIH) to develop new technology that would allow for the study of individual cells growing inside and outside the body believed to have a significant impact on human health. The human microbiome refers to the collection of microorganisms, which grow on and in a person's body and are thought to have an influence on their health...


-
Can-Fite BioPharma Announces The Initiation Of Phase 3 In Dry Eye Syndrome
Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome. In an earlier Phase 2 study, in which CF101 taken orally as a monotherapy for 12 weeks, a statistically significant benefit in the clearing of fluorescein staining in the nasal, temporal, pupillary and inferior parts of the cornea was documented...


-
Study: Preventive Services Can Saves Lives, Billions Of Dollars, At Little Or No Cost
Preventive health services such as daily aspirin use, tobacco cessation screening and alcohol abuse screening can potentially save 2 million lives and nearly $4 billion annually, according to a new paper produced by the National Commission on Prevention Priorities (NCPP). The NCPP is convened by the Partnership for Prevention. Four of the five lead authors perform research with HealthPartners Research Foundation. The paper, "Greater Use Of Preventive Services In U.S. Health Care Could Save Lives At Little Or No Cost," is published in the September issue of Health Affairs...


|
|